Targeting beta-cell cyclic 3 ` 5 ` adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review
- B Furman
- , N Pyne
- , Peter Flatt
- , Finbarr O'Harte
Research output: Contribution to journal › Article › peer-review
32
Link opens in a new tab
Citations
(Scopus)